Pancreatic Cancer Research

ResearcherArmy Medical UniversityNo recent work listed

Peng Jiang

Matched on ORCID iD 0000-0002-2650-3082; OpenAlex author ID A5027048963. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 2 papers · 2018: 4 papers

Papers 9

  1. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2018.04.035↗
  2. Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41388-018-0237-9↗
  3. Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer. Co-author DOI 10.1159/000495281↗
  4. Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor met… Co-author DOI 10.1186/s13046-018-0822-3↗
  5. MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1. Co-author DOI 10.18632/oncotarget.20692↗
  6. Fyn/heterogeneous nuclear ribonucleoprotein E1 signaling regulates pancreatic cancer metastasis by affecting the alternative splicing of integrin β1. Co-author DOI 10.3892/ijo.2017.4018↗
  7. The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer. Co-author DOI 10.1186/s13000-015-0445-3↗
  8. Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells. Co-author DOI 10.1016/j.toxlet.2013.10.007↗
  9. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer. Co-author DOI 10.1093/carcin/bgr088↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhonghu Li · 7 shared papers, 2015–2018 · strength 0.52
  2. Xiaowu Li · 7 shared papers, 2011–2018 · strength 0.47
  3. Jie Li · 4 shared papers, 2018 · strength 0.30
  4. Xiangde Liu · 2 shared papers, 2018 · strength 0.15
  5. Xin Zhao · 2 shared papers, 2018 · strength 0.15
  6. Yingqiang Xu · 2 shared papers, 2015–2017 · strength 0.13
  7. Guo Wu · 2 shared papers, 2015–2017 · strength 0.13
  8. Jin Yang · 1 shared paper, 2017 · strength 0.09
  9. Xi Zhang · 1 shared paper, 2017 · strength 0.08
  10. Tao Peng · 1 shared paper, 2018 · strength 0.08
  11. Xiaoya Wang · 1 shared paper, 2018 · strength 0.07
  12. Hui Liu · 1 shared paper, 2018 · strength 0.07
  13. Ping Bie · 2 shared papers, 2011–2014 · strength 0.07
  14. Lei-Da Zhang · 1 shared paper, 2014 · strength 0.04
  15. Dingguo Wu · 1 shared paper, 2014 · strength 0.04
  16. Huaizhi Wang · 1 shared paper, 2014 · strength 0.04
  17. Zhiyu Chen · 1 shared paper, 2011 · strength 0.02
  18. Shuguang Wang · 1 shared paper, 2011 · strength 0.02
  19. Lei Cai · 1 shared paper, 2011 · strength 0.02
  20. Zhihua Li · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.